Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
Publication year
2018Source
Targeted Oncology, 13, 5, (2018), pp. 641-648ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Oncology
Medical Imaging
Radboudumc Extern
Health Evidence
Clinical Pharmacy
Journal title
Targeted Oncology
Volume
vol. 13
Issue
iss. 5
Page start
p. 641
Page end
p. 648
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health SciencesThis item appears in the following Collection(s)
- Academic publications [227864]
- Faculty of Medical Sciences [86218]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.